REFERENCES

1. Schilsky ML, Roberts EA, Bronstein JM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2025;82:E41-90.

2. Nagral A, Sarma MS, Matthai J, et al. Wilson’s disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol. 2019;9:74-98.

3. Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012;56:671-85.

4. Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47:2089-111.

5. Guindi M. Wilson disease. Semin Diagn Pathol. 2019;36:415-22.

6. Alqahtani SA, Chami R, Abuquteish D, et al. Hepatic ultrastructural features distinguish paediatric Wilson disease from NAFLD and autoimmune hepatitis. Liver Int. 2022;42:2482-91.

7. Inherited Metabolic Liver Disease Collaboration Group, Chinese Society of Hepatology, Chinese Medical Association. [Guidelines for the diagnosis and treatment of hepatolenticular degeneration (2022 edition)]. Zhonghua Gan Zang Bing Za Zhi. 2022;30:9-20.

8. Doguer C, Ha J HandCollins J F. Intersection of iron and copper metabolism in the mammalian intestine and liver. Compr Physiol. 2018;8:1433-61.

9. Pak K, Ordway S, Sadowski B, Canevari M, Torres D. Wilson’s disease and iron overload: pathophysiology and therapeutic implications. Clin Liver Dis. 2021;17:61-6.

10. Dusek P, Bahn E, Litwin T, et al. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study. Neuropathol Appl Neurobiol. 2017;43:514-32.

11. Teschke R, Eickhoff A. Wilson disease: copper-mediated cuproptosis, iron-related ferroptosis, and clinical highlights, with comprehensive and critical analysis update. Int J Mol Sci. 2024;25:4753.

12. Su D, Zhang Z, Zhang Z, et al. Distinctive pattern of metal deposition in neurologic Wilson disease: insights from 7T susceptibility-weighted imaging. Neurology. 2024;102:e209478.

13. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23:139-42.

14. European Association for the Study of the Liver. EASL-ERN Clinical Practice Guidelines on Wilson’s disease. J Hepatol. ;2025:690-728.

15. Aggarwal A, Aggarwal N, Nagral A, Jankharia G, Bhatt M. A novel Global Assessment Scale for Wilson’s Disease (GAS for WD). Mov Disord. 2009;24:509-18.

16. Czlonkowska A, Tarnacka B, Moller J C, et al. Unified Wilson’s Disease Rating Scale - a proposal for the neurological scoring of Wilson’s disease patients. Neurol Neurochir Pol. 2007;41:1-12.

17. Campo CA, Hernando D, Schubert T, Bookwalter CA, Pay AJV, Reeder SB. Standardized approach for ROI-based measurements of proton density fat fraction and R2* in the liver. AJR Am J Roentgenol. 2017;209:592-603.

18. Verlhac S, Morel M, Bernaudin F, Béchet S, Jung C, Vasile M. Liver iron overload assessment by MRI R2* relaxometry in highly transfused pediatric patients: an agreement and reproducibility study. Diagn Interv Imaging. 2015;96:259-64.

19. Bannas P, Kramer H, Hernando D, et al. Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology. 2015;62:1444-55.

20. Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage. 2000;11:805-21.

21. Acosta-Cabronero J, Milovic C, Mattern H, Tejos C, Speck O, Callaghan MF. A robust multi-scale approach to quantitative susceptibility mapping. Neuroimage. 2018;183:7-24.

22. Dohan A, Vargas O, Dautry R, et al. MR imaging features of focal liver lesions in Wilson disease. Abdom Radiol. 2016;41:1811-24.

23. Su D, Zhang Z, Zhang Z, et al. Microstructural and functional impairment of the basal ganglia in Wilson’s disease: a multimodal neuroimaging study. Front Neurosci. 2023;17:1146644.

24. Fritzsch D, Reiss-Zimmermann M, Trampel R, Turner R, Hoffmann KT, Schäfer A. Seven-tesla magnetic resonance imaging in Wilson disease using quantitative susceptibility mapping for measurement of copper accumulation. Invest Radiol. 2014;49:299-306.

25. Dlouhy AC, Outten CE. The iron metallome in eukaryotic organisms. Met Ions Life Sci. 2013;12:241-78.

26. Scheiber IF, Bruha Rand Dusek P. Pathogenesis of Wilson disease. Handb Clin Neurol. 2017;142:43-55.

27. Shiono Y, Wakusawa S, Hayashi H, et al. Iron accumulation in the liver of male patients with Wilson’s disease. Am J Gastroenterol. 2001;96:3147-51.

28. Shribman S, Bocchetta M, Sudre CH, et al. Neuroimaging correlates of brain injury in Wilson’s disease: a multimodal, whole-brain MRI study. Brain. 2022;145:263-75.

29. Du J, Bydder GM. Brain atrophy is a better biomarker than susceptibility for evaluating clinical severity in Wilson disease. Radiology. 2021;299:673-4.

30. Dusek P, Lescinskij A, Ruzicka F, et al. Associations of brain atrophy and cerebral iron accumulation at MRI with clinical severity in Wilson disease. Radiology. 2021;299:662-72.

31. Jing XZ, Yuan XZ, Li GY, et al. Increased magnetic susceptibility in the deep gray matter nuclei of Wilson’s disease: have we been ignoring atrophy? Front Neurosci. 2022;16:794375.

32. Smolinski L, Ziemssen T, Akgun K, et al. Brain atrophy is substantially accelerated in neurological Wilson’s disease: a longitudinal study. Mov Disord. 2022;37:2446-51.

33. Rahimi P, Mareček S, Brůha R, et al. Brain morphometry in hepatic Wilson disease patients. J Inherit Metab Dis. 2025;48:e12814.

34. Tinaz S, Arora J, Nalamada K, et al. Structural and functional brain changes in hepatic and neurological Wilson disease. Brain Imaging Behav. 2021;15:2269-82.